Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion

British Journal of Dermatology

Volumn 137, Issue 2, 1997, Pages 171-178

  Le Poole, I C ^a,c   Van Den Wijngaard, R M J G J ^a   Westerhof, W ^a,b   Das, P K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Dutch Institute for Pigmentary Disorders (SNIP)   (Netherlands)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; TENASCIN;

ADULT; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MELANOCYTE; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; VITILIGO;

EID: 0030844764     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1997.18011894.x     Document Type: Article

References (40)

1. Le Poole IC, van den Wijngaard RMJGJ, Westerhof W et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993; 100: 816-22.
2. Morelli JG, Kincannon J, Yohn JJ et al. Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol 1992; 98: 290-5.
3. Hara M, Yaar M, Tang A et al. Role of integrins in melanocyte attachment and dendricity. J Cell Sci 1994; 107: 2739-48.
4. Morelli JG, Yohn JJ, Zekman T, Norris DA. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol 1993; 101: 605-8.
5. Puri N, Phil M, Mojamdar M, Ramaiah A. In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects. J Invest Dermatol 1987; 88: 434-8.
6. Boissy RE, Liu Y, Medrano EE, Nordlund JJ. Structural aberration of the endoplasmic reticulum and melanosome compartmentalization in long-term cultures from vitiligo patients. J Invest Dermatol 1991; 97: 395-404.
7. Boissy RE, Beato KE, Nordlund JJ. Dilated rough endoplasmic reticulum and premature death in melanocytes cultured from the vitiligo mouse. Am J Pathol 1991; 138: 1511-25.
8. 1) integrin receptors on T cells. Nature 1990; 345: 250-3.
9. Herlyn M, Graeven U, Speicher D et al. Characterization of tenascin secreted by human melanoma cells. Cancer Res 1991; 51: 4853-8.
10. O'Donnel DB, Saddler M, Aronson PJ, Sikha MVKN. Tenascin is abundant in the skin of vitiligo patients. J Invest Dermatol 1992; 98: 620 (Abstr).
11. Chiquet-Ehrismann R, Kalla P, Pearson CA et al. Tenascin interferes with fibronectin action. Cell 1988; 53: 383-90.
12. Lightner VA, Erickson HP. Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. J Cell Sci 1990; 95: 263-77.
13. Vennegoor C, Hageman P, van Nouhuys H et al. A monoclonal antibody specific for cells of the melanocyte lineage. Am J Pathol 1988; 130: 179-92.
14. Tomita Y, Yamamoto H, Sato C et al. Efficient culturing of human melanocytes from suction blisters. Tokohu J Exp Med 1985; 147: 219-20.
15. Eisinger M, Marko S. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 1982; 79: 2018-22.
16. Halaban R, Alfano FD. Selective elimination of fibroblasts from cultures of normal human melanocytes. In Vitro 1984; 20: 447-50.
17. Verstraeten AA, Mackie EJ, Hageman PC et al. Tenascin expression in basal cell carcinoma. Br J Dermatol 1992; 127: 571-4.
18. Gittay JC, Brinkman HJM, Modderman PW et al. Human vascular endothelial cells express a membrane protein complex immuno-chemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex. Blood 1989; 73: 1235-41.
19. Fraded J, Cordon-Cardo C, Thomson T et al. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci USA 1984; 81: 224-8.
20. Keizer GD, te Velde AA, Schwarting R et al. Role of p150,50 in adhesion, chemotaxis and phagocytosis of human monocytes. Eur J Immunol 1987; 17: 1317-22.
21. Sonnenberg A, Janssen H, Hogervorst F et al. A complex of platelet glycoproteins Ic and IIa defined by a rat monoclonal antibody J Biol Chem 1987; 264: 13745-50.
22. Morimoto C, Letvin NL, Boyd AW et al. The isolation and characterization of the human helper inducer T cell subset. J Immunol 1985; 134: 3762-9.
23. De Vries JE, Keizer GD, te Velde AA et al. Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells. Int J Cancer 1986; 38: 465-73.
24. Tetteroo PAT, Lansdorp PM, Leeksma OC, von dem Borne AEG. Monoclonal antibodies against human platelet glycoprotein IIIa. Br J Haematol 1983; 55: 509-51.
25. Hessle H, Sakai LY, Hollister DW et al. Basement membrane diversity detected by monoclonal antibodies. Differentiation 1984; 26: 49-54.
26. Danen EHJ, van Muyen GNP, van de Wiel-van Kemenade E et al. Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells. Int J Cancer 1993; 54: 315-21.
27. Le Poole IC, van den Wijngaard RMJGJ, Westerhof W et al. Organotypic culture of human skin to study melanocyte migration. Pigment Cell Res 1994; 7: 33-43.
28. Cui J, Shen J, Wang G. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991; 97: 410-16.
29. 4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol 1992; 98: 290-5.
30. Pesheva P, Probstmeier R, Skubitz APN et al. Tenasdn-R (JI 160/180) inhibits fibronectin-mediated cell adhesion - functional relatedness to tenascin-C. J Cell Sci 1994; 107: 2323-33.
31. Lightner GA, Erickson HP. Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. J Cell Sci 1990; 95: 263-77.
32. Chiquet-Ehrismann R, Kalla P, Pearson CA et al. Tenascin interferes with fibronectin action. Cell 1988; 53: 383-90.
33. Buffey JA, Messenger AG, Taylor M et al. Extracellular matrix derived from hair and skin fibroblasts stimulates human skin melanocyte tyrosinase activity. Br J Dermatol 1994; 131: 836-42.
34. Hann SK, Park YK, Chung KY et al. Peripheral blood lymphocyte imbalance in Koreans with active vitiligo. Int J Dermatol 1993; 32: 286-6.
35. Abdel-Nasr MB, Kruger-Krasagakes S, Krasagakis et al. Further evidence for the involvement of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res 1994; 1: 1-8.
36. Le Poole IC, van den Wijngaard RMJGJ, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996; 4: 1219-28.
37. Pearson CA, Pearson D, Shibahara S et al. Tenascin: cDNA cloning and induction by TGF-β. EMBO J 1988; 7: 2977-81.
38. Latijnhouwers M, Bergers M, Ponec M et al. Human epidermal keratinocytes are a source of tenascin-C during wound healing. J Invest Dermatol 1997; 108: 776-83.
39. Latijnhouwers M, Bergers M, Ponec M et al. Epidermal keratinocytes are a source of tenascin. In: XVth FECTS Meeting 1996; 1-12. (Abstr.).
40. Lightner VA. Tenascin: does it play a role in epidermal morphogenesis and homeostasis? J Invest Dermatol 1994; 102: 273-7.